News All News Contura Bulkamid Orthopaedics Animal Health Contura announces new CEO to accelerate future growth Date: 16 November 2021 Contura sells Bulkamid® to Axonics Modulation Technologies, Inc Date: 26 February 2021 Bulkamid: one year anniversary of FDA approval in the United States Date: 28 January 2021 Completion of prospective open label clinical study of Arthrosamid® for knee osteoarthritis Date: 9 October 2020 Completion of recruitment for a multi-center, randomized, controlled clinical study of Arthrosamid® for knee osteoarthritis. Date: 20 May 2020 Approval of Arthrosamid® for the treatment of knee osteoarthritis Date: 15 April 2020 Contura expands its commercial efforts to the US and appoints new US Leadership Team Date: 10 February 2020 FDA approves Bulkamid® in the United States and is now set for launch in Quarter 1 2020 Date: 31 January 2020 Results of Randomised Controlled Trial of Bulkamid® versus Tension-free Vaginal Tape Published Date: 1 January 2020 Urethral bulking agents to be considered as two distinct classes: particulate and non-particulate Date: 1 December 2019 Observational multicentered study shows that two thirds of women with stress urinary incontinence choose Bulkamid® when offered a choice Date: 1 December 2019 Completion of recruitment to a prospective, open-label clinical investigation of Arthrosamid for knee osteoarthritis Date: 17 October 2019 Commencement of a multi-center, randomized, controlled clinical study of Arthrosamid® for knee osteoarthritis Date: 15 June 2019 Acquisition of Manufacturing Facility in Copenhagen, Denmark Date: 25 May 2018 Searchlight Pharma Announces Launch of Bulkamid® for Treatment of Female Stress Urinary Incontinence Date: 10 May 2018 Speciality European Pharma Limited to rebrand as Contura in order to consolidate its corporate structure and drive growth Date: 19 January 2018 Contura files Bulkamid PMA Date: 30 July 2017 Speciality European Pharma sells Mitem to Substipharm Limited Date: 27 April 2017 Speciality European Pharma signs clinical research agreement with Central Manchester University Hospitals NHS Foundation Trust for the study of Bulkamid as a first line treatment for stress urinary incontinence Date: 17 February 2017 Speciality European Pharma extends distribution agreement for Regurin XL in the United Kingdom Date: 20 December 2016 MBO at SEP provides capital to accelerate growth and expansion Date: 1 May 2016 Contura signs clinical research agreement to initiate a randomised controlled trial of Bulkamid against Tension-free Vaginal Tape Date: 2 September 2015 Speciality European Pharma licenses distribution rights for Cystistat in Germany and France Date: 1 July 2015 Contura sells veterinary rights to Antematter Date: 30 December 2014 Contura terminates Bulkamid distribution rights with Ethicon Date: 3 May 2013 Speciality European Pharma acquires Contura A/S Date: 30 April 2013 Aquamid and Arthrosamid are registered trademarks of Contura International A/S. Contura Vet is a registered trademark of Contura Vet Ltd. Cystistat is a registered Trademark of Mylan Institutional Ltd. Privacy Notice © copyright 2021 Contura International Ltd.